Profile data is unavailable for this security.
About the company
ASKA Pharmaceutical Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company mainly operates in two business segments. The Pharmaceutical segment is mainly engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the manufacture of veterinary drugs, the provision of clinical testing services, the outsourcing of testing services, the purchase and sale of medical equipment, as well as the sale of health foods.
- Revenue in JPY (TTM)62.03bn
- Net income in JPY6.51bn
- Incorporated2021
- Employees747.00
- LocationASKA Pharmaceutical Holdings Co Ltd2-5-1, ShibauraMINATO-KU 108-8532JapanJPN
- Phone+81 354848845
- Fax+81 354848351
- Websitehttps://www.aska-pharma-hd.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fuji Pharma Co Ltd | 41.64bn | 5.06bn | 38.20bn | 1.62k | 7.41 | 0.8936 | 4.65 | 0.9173 | 208.19 | 208.19 | 1,713.27 | 1,726.70 | 0.5039 | 1.40 | 2.82 | 25,687,230.00 | 6.12 | 4.10 | 8.90 | 5.58 | 38.51 | 42.41 | 12.15 | 7.55 | 0.7165 | -- | 0.3947 | 31.17 | 15.42 | 1.52 | 27.41 | 0.3709 | 19.04 | 5.73 |
| Daito Pharmaceutical Co Ltd | 45.19bn | 3.28bn | 39.09bn | 1.01k | 11.98 | 0.7519 | 5.75 | 0.8649 | 207.85 | 207.85 | 2,864.81 | 3,311.81 | 0.6193 | 1.81 | 2.65 | 44,701,280.00 | 4.35 | 6.99 | 5.64 | 9.29 | 21.38 | 22.71 | 7.03 | 8.83 | 1.15 | -- | 0.1231 | 17.08 | 3.77 | 2.49 | -22.88 | 3.43 | 7.48 | 12.70 |
| Seikagaku Corp | 34.68bn | 1.31bn | 41.76bn | 976.00 | 30.62 | 0.5592 | 14.43 | 1.20 | 24.00 | 24.00 | 635.69 | 1,314.47 | 0.4431 | 1.75 | 4.31 | 35,530,740.00 | 1.67 | 0.438 | 1.80 | 0.4797 | 50.52 | 55.91 | 3.77 | 1.07 | 5.44 | -- | 0.0055 | 452.20 | -4.00 | 2.09 | -40.10 | -10.63 | 8.40 | 0.00 |
| Shin Nippon Biomedical Laboratories Ltd | 26.70bn | 5.50bn | 61.62bn | 1.21k | 11.20 | 2.04 | 8.46 | 2.31 | 132.18 | 132.18 | 641.45 | 725.03 | 0.4107 | 1.27 | 5.55 | 22,105,960.00 | 8.46 | 9.47 | 12.30 | 14.34 | 52.19 | 50.00 | 20.60 | 24.39 | 0.9618 | -- | 0.4687 | 23.01 | 41.37 | 8.61 | -14.98 | -- | 37.23 | -- |
| Katakura Industries Co., Ltd. | 39.97bn | 3.05bn | 64.65bn | 1.04k | 19.99 | 0.8111 | 10.98 | 1.62 | 91.86 | 91.86 | 1,206.19 | 2,263.56 | 0.2879 | 2.26 | 4.70 | 38,434,620.00 | 2.33 | 2.35 | 3.05 | 3.34 | 38.45 | 37.75 | 8.09 | 8.32 | 2.57 | -- | 0.1236 | 18.81 | 16.62 | -2.04 | 8.09 | 18.87 | -7.46 | 10.76 |
| ASKA Pharmaceutical Holdings Co Ltd | 62.03bn | 6.51bn | 69.01bn | 747.00 | 9.82 | 1.06 | 7.33 | 1.11 | 230.05 | 230.05 | 2,191.75 | 2,131.76 | 0.6682 | 1.72 | 3.40 | 83,033,460.00 | 7.02 | 3.37 | 9.09 | 4.25 | 48.12 | 45.39 | 10.50 | 5.02 | 1.96 | -- | 0.1433 | 15.79 | 6.81 | 4.32 | -1.21 | 12.16 | -13.15 | 2.71 |
| ispace Inc | 1.99bn | -2.52bn | 69.10bn | 216.00 | -- | 16.66 | -- | 34.70 | -33.88 | -33.88 | 24.76 | 44.55 | 0.1476 | -- | 24.87 | 9,219,852.00 | -18.66 | -- | -32.11 | -- | 46.91 | -- | -126.42 | -- | 1.72 | -16.56 | 0.7317 | -- | 46.74 | -- | -180.75 | -- | -- | -- |
| Eiken Chemical Co Ltd | 39.90bn | 2.95bn | 81.08bn | 754.00 | 25.69 | 1.49 | 15.48 | 2.03 | 78.83 | 78.83 | 1,067.99 | 1,355.09 | 0.6013 | 2.74 | 3.07 | 52,923,080.00 | 4.44 | 8.83 | 5.45 | 11.34 | 42.67 | 46.39 | 7.38 | 12.16 | 2.95 | -- | 0.0563 | 31.24 | 0.6396 | 4.34 | -7.75 | 17.07 | 0.6216 | 15.33 |
| JCR Pharmaceuticals Co Ltd | 41.37bn | 5.36bn | 102.84bn | 879.00 | 18.54 | 1.78 | 12.56 | 2.49 | 42.78 | 42.78 | 330.47 | 445.94 | 0.4253 | 0.5492 | 3.03 | 47,059,160.00 | 5.53 | 9.63 | 8.38 | 14.67 | 74.83 | 74.34 | 12.99 | 19.32 | 1.15 | 19.24 | 0.294 | 27.35 | -32.77 | 10.77 | -74.00 | 4.20 | 53.67 | 25.21 |
Data as of Apr 26 2024. Currency figures normalised to ASKA Pharmaceutical Holdings Co Ltd's reporting currency: Japanese Yen JPY
12.64%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 05 Apr 2024 | 686.00k | 2.25% |
| Dimensional Fund Advisors LPas of 28 Mar 2024 | 660.48k | 2.16% |
| Nomura Asset Management Co., Ltd.as of 29 Mar 2024 | 622.70k | 2.04% |
| Amundi Japan Ltd.as of 29 Feb 2024 | 510.40k | 1.67% |
| Dalton Investments, Inc.as of 08 Apr 2024 | 368.80k | 1.21% |
| Nikko Asset Management Co., Ltd.as of 05 Apr 2024 | 326.50k | 1.07% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 287.40k | 0.94% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 12 Dec 2022 | 171.80k | 0.56% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 162.30k | 0.53% |
| LSV Asset Managementas of 28 Mar 2024 | 67.90k | 0.22% |
More ▼
Data from 31 Dec 2023 - 08 Apr 2024Source: FactSet Research Systems Inc.
